spinal muscular atrophy type 3
GPTKB entity
Statements (52)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:muscular_dystrophy
|
gptkbp:affects |
motor neurons
|
gptkbp:caused_by |
gptkb:SMN1_gene_mutation
|
gptkbp:clinical_trial |
difficulty swallowing
respiratory issues hypotonia twitching muscles proximal muscle weakness |
gptkbp:condition |
gptkb:spinal_muscular_atrophy_type_2
gptkb:spinal_muscular_atrophy_type_1 spinal muscular atrophy type 4 |
gptkbp:diagnosis |
variable
genetic testing family history clinical evaluation neurological examination |
gptkbp:epidemiology |
1 in 10,000 births
more common in certain populations |
gptkbp:genetic_studies |
recommended for families
SMN2 gene copy number SMN1 gene analysis |
https://www.w3.org/2000/01/rdf-schema#label |
spinal muscular atrophy type 3
|
gptkbp:inherits_from |
autosomal recessive
|
gptkbp:is_affected_by |
gptkb:children
adults |
gptkbp:is_involved_in |
gptkb:Cure_SMA
gptkb:SMA_Foundation SMA Support UK |
gptkbp:lifespan |
normal to near normal
|
gptkbp:premiered_on |
childhood
|
gptkbp:public_awareness |
advocacy for research funding
important for early diagnosis |
gptkbp:research |
gptkb:gene_therapy
clinical trials |
gptkbp:research_institutes |
gptkb:Cure_SMA
gptkb:MDA gptkb:NIH |
gptkbp:symptoms |
fatigue
difficulty walking muscle weakness tremors muscle wasting scoliosis joint contractures |
gptkbp:treatment |
gptkb:risdiplam
gptkb:Zolgensma gptkb:nusinersen medications physical therapy supportive care |
gptkbp:bfsParent |
gptkb:Nusinersen
|
gptkbp:bfsLayer |
5
|